Your browser doesn't support javascript.
loading
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
Burgess, Earle F; Livasy, Chad A; Symanowski, James T; Matulay, Justin T; Grigg, Claud M; Clark, Peter E; Raghavan, Derek.
Afiliación
  • Burgess EF; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC. Electronic address: earle.burgess@atriumhealth.org.
  • Livasy CA; Department of Pathology, Atrium Health, Levine Cancer Institute, Charlotte, NC.
  • Symanowski JT; Department of Biostatistics and Data Sciences, Atrium Health, Levine Cancer Institute, Charlotte, NC.
  • Matulay JT; Department of Urology, Atrium Health, Charlotte, NC.
  • Grigg CM; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC.
  • Clark PE; Department of Urology, Atrium Health, Charlotte, NC.
  • Raghavan D; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC.
Urol Oncol ; 41(8): 357.e23-357.e29, 2023 08.
Article en En | MEDLINE | ID: mdl-37295980
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article